CURRENT AFFAIRS

Detailed explanation-1: -India’s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine for COVID-19, CORBEVAXTM, developed by Biological E Limited,has received approval for Emergency Use Authorization from the Drug Controller General of India (DCGI)for 12-18 years age group.

Detailed explanation-2: -Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh announces India’s first indigenously developed vaccine, “CERVAVAC” for the prevention of cervical cancer.

Detailed explanation-3: -The Drug Controller General of India (DCGI) has granted emergency use authorisation (EUA) for GEMCOVAC-19, the country’s first indigenously developed mRNA Covid-19 vaccine.

Detailed explanation-4: -The ZyCoV-D is the world’s first and India’s indigenously developed DNA based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above.

Detailed explanation-5: -The first subunit vaccine to be approved for use in humans in the United States is the hepatitis B vaccine, which comprises hepatitis B virus surface antigens (HBsAg) that originate from the hepatitis B virus.